Rhinal Therapeutics Inc. — Form D

Rhinal Therapeutics Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-07. The offering totals $1.0M, of which $20K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-08-07
• Form: D
• Accession: 0002080382-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $20K
• Remaining: $980K
• Investors: 1
• Date of first sale: 2025-07-28
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-554015

Issuer

• Name: Rhinal Therapeutics Inc.
• CIK: 0002080382
• Entity type: Corporation
• Jurisdiction: NEVADA
• Incorporated: 2023
• Address: 732 S 6TH ST, LAS VEGAS, NV, 89101
• Phone: 7029816980

Officers, directors & promoters (8)

More

• CIK 2080382 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search